AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E401794-T1: [Translated] CHEESE PRODUCTS WITH A SOFT EXTRUSION CHEESE TEXTURE AND A TASTE OF FERMENTED MILK PRODUCT AND METHOD FOR PRODUCING THESE CHEESE PRODUCTS

Method for producing novel cheese products having a fibrous texture and a fresh and lactic taste by processing an initial raw material which includes a drawn-curd cheese having a firm and fibrous texture, adding a defined quantity of fermented milk product and processing the mixture.
Cloud Computing Service Models Webinar

This webinar, featuring Terry Watt (Director, Division of State Systems), Nicole Harter-Shafer (Federal Analyst, Division of State Systems), and Nick Gompper (contracted technology specialist), provided technical assistance about cloud service computing models.  The webinar distinguished between Infrastructure-as-a-Service, Platform-as-a-Service, Software-as-a-Service, and Commercial-off-the-Shelf (COTS) solutions and the webinar included items to consider when evaluating solutions for a specific title IV-E agency need.  In addition, Terry Watt and Nicole Harter-Shafer provided technical assistance about selecting a solution, when to use a COTS waiver, and sole-source justification.  The webinar included several question and answer sessions throughout the presentation.

Metadata-only record linking to the original dataset. Open original dataset below.
National Survey of Substance Abuse Treatment Services (N-SSATS): 2007 Data on Substance Abuse Treatment Facilities

This report presents results from the 2007 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the N-SSATS is designed to collect data on the location, characteristics, and use of alcoholism and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
Elk Creek Seismic Waveforms 2012 (Part 18 of 20)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 45 of 48 and corresponds to the time range between November 12, 2012, and November 26, 2012.
Compound 528363: 2,4,6-Trimethyl-1,3,5-thiadiazinane

Chemical compound data from PubChem database. IUPAC Name: 2,4,6-trimethyl-1,3,5-thiadiazinane. Molecular Formula: C6H14N2S. Molecular Weight: 146.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525106: 2,3-Dichloropropyl decanoate

Chemical compound data from PubChem database. IUPAC Name: 2,3-dichloropropyl decanoate. Molecular Formula: C13H24Cl2O2. Molecular Weight: 283.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
MD COVID-19 - Probable Deaths by Age Distribution

<b>Note:</b> Starting April 27, 2023 updates change from daily to weekly.

<b>Summary</b>
The cumulative number of probable COVID-19 deaths among Maryland residents by age: 0-9; 10-19; 20-29; 30-39; 40-49; 50-59; 60-69; 70-79; 80+; Unknown.

<b>Description</b>
The MD COVID-19 - Probable Deaths by Age Distribution data layer is a collection of the statewide confirmed and probable COVID-19 related deaths that have been reported each day by the Vital Statistics Administration by designated age ranges. A death is classified as probable if the person's death certificate notes COVID-19 to be a probable, suspect or presumed cause or condition. Probable deaths are not yet been confirmed by a laboratory test. Some data on deaths may be unavailable due to the time lag between the death, typically reported by a hospital or other facility, and the submission of the complete death certificate. Confirmed deaths are available from the MD COVID-19 - Confirmed Deaths by Age Distribution data layer.

<b>Terms of Use</b>
The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Connexin-mimetic peptide Gap 27 decreases osteoclastic activity

Background
          Bone remodelling is dependent on the balance between bone resorbing osteoclasts and bone forming osteoblasts. We have shown previously that osteoclasts contain gap-junctional protein connexin-43 and that a commonly used gap-junctional inhibitor, heptanol, can inhibit osteoclastic bone resorption. Since heptanol may also have some unspecific effect unrelated to gap-junctional inhibition we wanted to test the importance of gap-junctional communication to osteoclasts using a more specific inhibitor.
        
        
          Methods
          A synthetic connexin-mimetic peptide, Gap 27, was used to evaluate the contribution of gap-junctional communication to osteoclastic bone resorption. We utilised the well-characterised pit-formation assay to study the effects of the specific gap-junctional inhibitor to the survival and activity of osteoclasts.
        
        
          Results
          Gap 27 caused a remarked decrease in the number of both TRAP-positive mononuclear and multinucleated rat osteoclasts cultured on bovine bone slices. The decrease in the cell survival seemed to be restricted to TRAP-positive cells, whereas the other cells of the culture model seemed unaffected. The activity of the remaining osteoclasts was found to be diminished by measuring the percentage of osteoclasts with actin rings of all TRAP-positive cells. In addition, the resorbed area in the treated cultures was greatly diminished.
        
        
          Conclusions
          On the basis of these results we conclude that gap-junctional communication is essential for the action of bone resorbing osteoclasts and for proper remodelling for bone.
2007 CMHS Uniform Reporting System Output Tables

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2007. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence-based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 526809: 17-Hydroxy-stearic acid, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 17-[tert-butyl(dimethyl)silyl]oxyoctadecanoate. Molecular Formula: C25H52O3Si. Molecular Weight: 428.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401732-T1: [Translated] NETWORK GAME SYSTEM, GAME SERVER AND METHOD FOR DISPLAYING ADVERTISING

The system has a network game server (10) retrieving an event information and advertisement information associated with personal utilization history information of a player operating a game terminal (20, 22, 24), from a database of the server. The history information is displayed on an image display device. The terminal has a drawing unit to generate a game screen displayed by the device by using the stored event information. An independent claim is also included for an advertisement displaying method executed in a network game system including a network game server and a game terminal connected to the network game server.
National Database for Autism Research (NDAR)

<p>National Database for Autism Research (NDAR) is an extensible, scalable informatics platform for autism spectrum disorder-relevant data at all levels of biological and behavioral organization (molecules, genes, neural tissue, behavioral, social and environmental interactions) and for all data types (text, numeric, image, time series, etc.). NDAR was developed to share data across the entire ASD field and to facilitate collaboration across laboratories, as well as interconnectivity with other informatics platforms.</p>

<p> NDAR Homepage: http://ndar.nih.gov/</p>
Compound 527837: Propanoic acid, 3-amino-2-methyl, butyl ester, TFA

Chemical compound data from PubChem database. IUPAC Name: butyl 2-methyl-3-[(2,2,2-trifluoroacetyl)amino]propanoate. Molecular Formula: C10H16F3NO3. Molecular Weight: 255.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome

NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome  - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Patent AT-E400204-T1: [Translated] FLOOR

A cane includes a top (12) connected to a shaft (14) having a first compartment (18), a second compartment (20) and at least a third compartment (22). The cane includes a first flask (25) for holding fluid and removably disposed in the first compartment. The cane includes a second flask (26) for holding fluid and removably disposed in the second compartment. The cane includes at least a third flask (28) for holding fluid and removably disposed in the third compartment. A method for storing materials in a cane and a method of forming a cane are claimed as well. Further a carrying device is provided comprising at least one flask for holding liquid, a case which holds the flask and means for storing information disposed in the case. <IMAGE>
Compound 528563: Lactic acid, diTBDMS

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-[tert-butyl(dimethyl)silyl]oxypropanoate. Molecular Formula: C15H34O3Si2. Molecular Weight: 318.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?

Background
          Mefloquine is a clinically important antimalaria drug, which is often not well tolerated. We critically reviewed 516 published case reports of mefloquine adverse effects, to clarify the phenomenology of the harms associated with mefloquine, and to make recommendations for safer prescribing.
        
        
          Presentation
          We postulate that many of the adverse effects of mefloquine are a post-hepatic syndrome caused by primary liver damage. In some users we believe that symptomatic thyroid disturbance occurs, either independently or as a secondary consequence of the hepatocellular injury. The mefloquine syndrome presents in a variety of ways including headache, gastrointestinal disturbances, nervousness, fatigue, disorders of sleep, mood, memory and concentration, and occasionally frank psychosis. Previous liver or thyroid disease, and concurrent insults to the liver (such as from alcohol, dehydration, an oral contraceptive pill, recreational drugs, and other liver-damaging drugs) may be related to the development of severe or prolonged adverse reactions to mefloquine.
        
        
          Implications
          We believe that people with active liver or thyroid disease should not take mefloquine, whereas those with fully resolved neuropsychiatric illness may do so safely. Mefloquine users should avoid alcohol, recreational drugs, hormonal contraception and co-medications known to cause liver damage or thyroid damage. With these caveats, we believe that mefloquine may be safely prescribed in pregnancy, and also to occupational groups who carry out safety-critical tasks.
        
        
          Testing
          Mefloquine's adverse effects need to be investigated through a multicentre cohort study, with small controlled studies testing specific elements of the hypothesis.
A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer

Background
          Electroporation of skeletal muscle after injection of naked DNA was shown by others to increase transgene expression. Information regarding tissue damage caused by electroporation is conflicting. It is also not well known how plasmid electroporation compares with transfection by adenoviral vectors. To investigate these questions the most used protocol for muscle electroporation was used, i.e. 8 pulses of 200 V/cm and 20 ms at a frequency of 1 Hz.
        
        
          Results
          Intra-muscular DNA transfer of pLuciferase was increased by 2 logs after electroporation, confirming data described by others. However, the blood levels of the encoded protein were still lower than those obtained after injection of first generation adenoviral vectors. Also, the electroporation procedure, on its own, caused severe muscle damage consisting of rhabdomyolysis and infiltration, whereas the adenoviral vectors caused only a slight infiltration. As damage of targeted tissue may be an advantage in the case of tumour transfection, we also compared the two transfection methods in tumour tissue. In case of poorly permissive tumours, adenoviral vectors cannot transfect more than 2% of the tumour tissue without inducing significant liver damage. In contrast, the electroporation seems to offer a wider therapeutic window since it does not cause any systemic toxicity and still induce's significant transfection.
        
        
          Conclusions
          Plasmid electroporation of the muscle induce severe local damage and is of no advantage over adenoviral vectors for obtaining high blood levels of a vector encoded protein. In contrast, electroporation of tumours might be safer than adenoviral gene transfer.
Patent AT-E40084-T1: [Translated] DISPENSER.

PCT No. PCT/EP84/00377 Sec. 371 Date Aug. 1, 1985 Sec. 102(e) Date Aug. 1, 1985 PCT Filed Nov. 30, 1984 PCT Pub. No. WO85/02598 PCT Pub. Date Jun. 20, 1985.With a metering dispenser (1) for compactates with a compactate store (3) and a metering disk (4) arranged pivotably around an axis (A) with respect to the store, containing several chambers (27) for accommodating individual compactates, in order to perform dispensing with sufficient reliability in the quantitative dispensing of the individual components in the household sector, given an essentially cylindrical design as well as relative rotatability of the store (3) and the metering disk (4) around the cylinder axis (A) the combination is provided with a metering cup (2) for liquid or free-flowing product. The metering dispenser (1) can be formed as a closure for a storage container accommodating one of the components, so that a multi-component package is present.
National Survey of Substance Abuse Treatment Services: State Profiles 2017

The 2017 National Survey of Substance Abuse Treatment Services (N-SSATS) is an annual survey of facilities providing substance abuse treatment. The N-SSATS, conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), is designed to collect data on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse facilities (both public and private) throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
Compound 529774: 2,5-dimethyl-8-propan-2-yl-3,4,4a,5,6,7,8,8a-octahydro-1H-naphthalen-2-ol

Chemical compound data from PubChem database. IUPAC Name: 2,5-dimethyl-8-propan-2-yl-3,4,4a,5,6,7,8,8a-octahydro-1H-naphthalen-2-ol. Molecular Formula: C15H28O. Molecular Weight: 224.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529749: (2,7,7-Trimethyl-6-bicyclo[3.1.1]hept-2-enyl) 2-methylpropanoate

Chemical compound data from PubChem database. IUPAC Name: (2,7,7-trimethyl-6-bicyclo[3.1.1]hept-2-enyl) 2-methylpropanoate. Molecular Formula: C14H22O2. Molecular Weight: 222.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Differential modulation of cellular death and survival pathways by conjugated bile acids

Background
          The liver-derived McNtcp.24 cells transport bile acids and show distinctive responses to the two classes of conjugated bile acids. Whereas taurine-conjugated bile acids are non-toxic, glycine-conjugated bile acids efficiently induce apoptosis. The aim of this study was to determine if the differential sensitivity is limited to cells that normally transport bile acids and if bile acid binding proteins could reduce bile acid-mediated apoptosis. The apical sodium/bile acid co-transporter (asbt) was expressed in Chinese hamster ovary (CHO) cells to establish active bile acid transport in a non-liver-derived cell model (CHO.asbt). A high-affinity bile acid binder was expressed in McNtcp.24 cells.
        
        
          Results
          The tolerance of McNtcp.24 cells to taurine-conjugated bile acids was associated with the stimulation of phosphatidylinositol 3-kinase (PI3K) activity. Treatment of CHO.asbt cells with taurine- and glycine-conjugated bile acids resulted in apoptosis. Unlike in McNtcp.24 cells, PI3K activity was not increased in CHO.asbt cells treated with taurine-conjugated bile acids. High level expression of a bile acid binder did not attenuate bile acid-induced cytotoxicity in McNtcp.24 cells.
        
        
          Conclusion
          The data suggest that McNtcp.24 cells possess a mechanism that can elaborate distinctive responses to the different classes of bile acids. Additionally, activation of a signaling pathway involving PI3K appears to be the dominant mechanism responsible for the tolerance of McNtcp.24 cells to taurine-conjugated bile acids.
The Use of Web Services in Data Exchanges

This presentation provides an overview of web services, how they use different types of patterns, and their purpose in effectively exchanging data in real time between heterogeneous systems. The presentation introduces the concept of service-oriented architecture using web services and how these web services can be used to integrate diverse repositories of data as well as to create efficient solutions for sharing and accessing data across the enterprise.

The speaker for this presentation is Valter Borges, director, Information Systems, State of Connecticut Department of Children and Families.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E39993-T1: [Translated] INDUSTRIAL BURNER FOR GASEOUS OR LIQUID FUELS.

A burner for gaseous or liquid fuel for heating furnaces includes a ceramic combustion chamber (20) for incomplete combustion of the fuel with primary air from which hot gases exit at high velocity through a constricted outlet (24). The combustion chamber is surrounded by a chamber (42) for the preheated remainder air necessary to complete combustion. Out of this chamber high velocity jets of air issue through nozzle openings encircling the combustion chamber outlet. Energy is saved and simple construction maintained by providing a tubular heat recuperator (4, 7, 9) rearwardly of the combustion chamber in which a cylindrical wall of temperature resistant steel passes to separate the recuperator into two annular chambers (10,11) and extends forward over a large part of the axial length of the combustion chamber so as to form an outer boundary of the remainder air chamber. The forward extension of the cylindrical wall (9) has an inturned rim constituting the ring-shaped nozzle carrier (33) in which the nozzle openings for the remainder air jets are provided. The combustion chamber is clamped between its spring-loaded fuel pipe (16) and the nozzle carrying rim (33) of the cylindrical wall (9).